FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Beryl Drugs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524606 P/E (TTM) :0
ISIN Demat:INE415H01017 Div & Yield %:0 EPS (TTM) :0.03
Book Value (RS) :18.6259045 Market Cap (Rs Cr.):10.85 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 3.78 5.31 -28.81
Other Income 0.00 0.00 0.00
PBIDT -0.20 0.59 -133.90
Interest 0.09 0.12 -25.00
PBDT -0.29 0.47 -161.70
Depreciation 0.32 0.31 3.23
PBT -0.61 0.16 -481.25
Tax -0.18 0.07 -357.14
Deferred Tax -0.26 0.03 -966.67
PAT -0.17 0.05 -440.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)